Acciones Generex Biotechnology Corporation OTC Bulletin Board
Acciones
US3714851033
Biotecnología e investigación médica
Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
|
2022 | Petición involuntaria aprobada para Generex Biotechnology Corporation | CI |
2022 | Petición involuntaria presentada contra Generex Biotechnology Corporation | CI |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joseph Moscato
CEO | Chief Executive Officer | 61 | 21/11/17 |
Mark Carrao
DFI | Director of Finance/CFO | - | 01/01/17 |
Terry Thompson
COO | Chief Operating Officer | 65 | 25/06/18 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Brian T. McGee
BRD | Director/Board Member | 63 | 01/03/04 |
Eric von Hofe
PRN | Corporate Officer/Principal | 66 | 01/01/05 |
Craig Eagle
BRD | Director/Board Member | 57 | 21/11/17 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+16,42 % | 124 mil M | |
+19,02 % | 112 mil M | |
+3,52 % | 22,94 mil M | |
-11,63 % | 17,02 mil M | |
-16,50 % | 16,88 mil M | |
-39,57 % | 16,87 mil M | |
+2,68 % | 13,63 mil M | |
+21,16 % | 11,61 mil M | |
+108,78 % | 10,31 mil M |